Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Project aims to boost science pass rate
2009-01-19

 
Attending the launch of the HP grant of about R1 million to the UFS are, from the left: Mr Leon Erasmus, Country Manager for HP Technology Services in South Africa, Prof. Teuns Verschoor, Acting Rector of the UFS, and Mr Cobus van Breda, researcher at the UFS's Centre for Education Development and manager of the project.
Photo: Lacea Loader
The University of the Free State (UFS), in partnership with computer giant Hewlett Packard (HP), wants to boost the pass rate of its science students by using mobile technology.

The UFS is one of only 15 universities across Europe, the Middle East and Africa and the only university in South Africa to receive a grant from HP to promote mobile technology for teaching in higher education valued at USD$ 100,000 (or about R1 million). Altogether 80 universities from 28 countries applied for the grant.

“Last year HP invited a number of selected universities to submit proposals in which they had to explain how they are going to utilise mobile technologies in the redesign of a course that is presented at the university. The proposal of the Centre for Education Development (CED) at the UFS entitled “Understanding Physics through data logging” was accepted,” says Mr Cobus van Breda, researcher at CED and manager of the project.

According to Mr van Breda, students who do not meet the entrance requirements for the three-year B.Sc. programme have to enroll for the four-year curriculum with the first year actually preparing them for the three-year curriculum.

In order to increase the success rate of these students, the project envisages to enhance their understanding of science principles by utilising the advantages of personal computer (PC) tablet technology and other information and communication technologies (ICT) to support effective teaching and learning methodology.

“By using PC tablet technology in collaboration with data-logging software, a personal response system, the internet and other interactive ICT applications, an environment different from a traditional teaching milieu is created. This will consequently result in a different approach to addressing students’ learning issues,” says Mr van Breda.

The pilot project was launched during the fourth term of 2008 when 130 first-year B.Sc. students (of the four-year curriculum) did the practical component of the physics section of the Concepts in General Science (CGS) module by conducting experiments in a computerised laboratory, using data-logging software amongst other technology applications. “The pilot project delivered good results and students found the interactive application very helpful,” says Mr van Breda.

”The unique feature of the latter is the fact that real-life data can be collected with electronic sensors and instantly presented as computer graphs. It can then be analysed and interpreted immediately, thus more time can be devoted to actual Science principles and phenomena and less time on time-consuming data processing,” says Mr van Breda.

The CGS module can be seen as a prerequisite for further studies in physics at university level and in this regard it is of essence to keep looking for new models of learning and teaching which can result in student success. This year the theoretical and practical component of the physics section of the CGS programme will be done in an integrated manner.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
16 January 2009
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept